Charlotte's Web Holdings, Inc. (CWBHF)
OTCMKTS
· Delayed Price · Currency is USD
0.1000
+0.0100 (11.11%)
May 14, 2025, 4:00 PM EDT
Charlotte's Web Holdings Employees
Charlotte's Web Holdings had 112 employees as of December 31, 2024. The number of employees decreased by 52 or -31.71% compared to the previous year.
Employees
112
Change (1Y)
-52
Growth (1Y)
-31.71%
Revenue / Employee
$444,688
Profits / Employee
-$235,929
Market Cap
15.90M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
CytoDyn | 9 |
Glass House Brands | 374 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Charlotte's Web Holdings News
- 1 day ago - Charlotte's Web Reports Year-Over-Year Growth For Q1 2025 - PRNewsWire
- 2 months ago - Charlotte's Web Holdings Inc. (CWBHF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Charlotte's Web Reports 2024 Fourth Quarter and Year-End Financial Results - PRNewsWire
- 2 months ago - Charlotte's Web 2024 Fourth Quarter Earnings Call and Webcast Notice - PRNewsWire
- 2 months ago - Charlotte's Web Announces DeFloria to enter Phase 2 FDA Clinical Trial for Autism Spectrum Disorder Treatment - PRNewsWire
- 2 months ago - DeFloria Receives Investigational New Drug Application Clearance from FDA for Phase 2 Clinical Trial of AJA001, an Oral Cannabinoid Drug Being Developed for the Treatment of Autism Spectrum Disorder (ASD) - PRNewsWire
- 5 months ago - Charlotte's Web Provides Update on DeFloria's Phase 1 Results Targeting Autism Spectrum Disorder - PRNewsWire
- 5 months ago - DeFloria Announces Positive Results from Phase 1 Trial of AJA001 Being Developed for the Treatment of Autism Spectrum Disorder (ASD) - PRNewsWire